Simone JV. A history of St Jude Children’s Research Hospital. Br J Haematol. 2003;120:549–55 https://doi.org/10.1046/J.1365-2141.2003.04111.X.
Article
Google Scholar
Frei E, Karon M, Levin RH, Freireich EJ, Taylor RJ, Hananian J, et al. The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood. 1965;26:642–56 https://doi.org/10.1182/BLOOD.V26.5.642.642.
Article
Google Scholar
Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349:640–9. https://doi.org/10.1056/NEJMOA035091.
Article
PubMed
Google Scholar
Pinkel D. The ninth annual David Karnofsky lecture. Treatment of acute lymphocytic leukemia Cancer. 1979;43:1128–37 https://doi.org/10.1002/1097-0142(197903)43:3<1128::aid-cncr2820430352>3.0.co;2-y.
Simone JV, Aur RJ, Hustu HO, Verzosa M, Pinkel D. Combined modality therapy of acute lymphocytic leukemia. Cancer. 1975;35:25–35 https://doi.org/10.1002/1097-0142(197501)35:1<25::aid-cncr2820350105>3.0.co;2-s.
Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia. 30 years’ experience at St. Jude Children’s Research Hospital. N Engl J Med. 1993;329:1289–1295. https://doi.org/10.1056/NEJM199310283291801.
Pinkel DP, Simone J V, Hustu HO, J R. “Total therapy” of childhood acute lymphocytic leukemia. Pediatr Res 1971 58 1971;5:408–408. https://doi.org/10.1203/00006450-197108000-00155.
Ortega JA, Nesbit MEJ, Donaldson MH, Hittle RE, Weiner J, Karon M, et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res. 1977;37:535–40.
CAS
PubMed
Google Scholar
T T, M A-H. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577. https://doi.org/10.1038/BCJ.2017.53.
Pinkel D. Five-year follow-up of total therapy of childhood lymphocytic leukemia. JAMA. 1971;216:648–652. https://doi.org/10.1001/JAMA.1971.03180300032007.
CS H, JE K. Minimal residual disease in acute myeloid leukaemia. Nat Rev Clin Oncol. 2013;10:460–471. https://doi.org/10.1038/NRCLINONC.2013.100.
Pinkel D, Hernandez K, Borella L, Holton C, Aur R, Samoy G, et al. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer. 1971;27:247–56 https://doi.org/10.1002/1097-0142(197102)27:2<247::AID-CNCR2820270202>3.0.CO;2-C.
Simone J, Aur RJA, Hustu HO, Pinkel D. “Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer. 1972;30:1488–94 https://doi.org/10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D.
Aur RJ, Simone J, Hustu HO, Walters T, Borella L, Pratt C, et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood. 1971;37:272–81 https://doi.org/10.1182/BLOOD.V37.3.272.272.
Article
CAS
Google Scholar
George P, Hernandez K, Hustu O, Borella L, Holton C, Pinkel D. A study of “total therapy” of acute lymphocytic leukemia in children. J Pediatr. 1968;72:399–408. https://doi.org/10.1016/S0022-3476(68)80217-3.
Article
CAS
PubMed
Google Scholar
Pinkel D, Simone J, Hustu HO, Aur RJA. Nine years’ experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics. 1972;50.
Aur RJA, Simone JV, Hustu HO, Verzosa MS. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer. 1972;29:381–91 https://doi.org/10.1002/1097-0142(197202)29:2<381::AID-CNCR2820290219>3.0.CO;2-P.
Aur RJA, Simone JV, Pratt CB. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure. Cancer. 1971;27:1332–6 https://doi.org/10.1002/1097-0142(197106)27:6<1332::AID-CNCR2820270609>3.0.CO;2-O.
Aur RJA, Hustu HO, Verzosa MS. Comparison of two methods of preventing central nervous system leukemia. Blood. 1973;42:349–57 https://doi.org/10.1182/BLOOD.V42.3.349.349.
Article
CAS
Google Scholar
Simone JV. Factors that influence haematological remission duration in acute lymphocytic leukaemia. Br J Haematol. 1976;32:465–72 https://doi.org/10.1111/j.1365-2141.1976.tb00950.x.
Article
CAS
Google Scholar
Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol. 1998;16:3761–7. https://doi.org/10.1200/JCO.1998.16.12.3761.
Article
CAS
PubMed
Google Scholar
Aur RJA, Simone JV, Verzosa MS, Hustu HO, Barker LF, Pinkel DP, et al. Childhood acute lymphocytic leukemia. Study VIII Cancer. 1978;42:2123–34 https://doi.org/10.1002/1097-0142(197811)42:5<2123::AID-CNCR2820420507>3.0.CO;2-5.
Pui CH, Dodge RK, Look AT, George SL, Rivera GK, Abromowitch M, et al. Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol. 1991;9:1341–1347. https://doi.org/10.1200/JCO.1991.9.8.1341.
Pui C-H, Aur RJA, Bowman WP, Dahl GV, Dodge RK, George SL, et al. Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia. Cancer Res. 1984;44.
Pui CH, Ochs J, Kalwinsky DK, Costlow ME. Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia. Leuk Res. 1984;8:345–50. https://doi.org/10.1016/0145-2126(84)90073-0.
Article
CAS
PubMed
Google Scholar
Abromowitch M, Ochs J, Pui CH, Kalwinsky D, Rivera GK, Fairclough D, et al. High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X. Med Pediatr Oncol. 1988;16:297–303. https://doi.org/10.1002/MPO.2950160502.
Hijiya N, Liu W, Sandlund IT, Jeha S, Razzouk BI, Ribeiro RC, et al. Overt testicular disease at diagnosis of childhood acute lymphoblastic leukemia: lack of the therapeutic role of local irradiation. Leukemia. 2005;19:1399–403 https://doi.org/10.1038/sj.leu.2403843.
Article
CAS
Google Scholar
Pui CH, Pei D, Sandlund JT, Ribeiro RC, Rubnitz JE, Raimondi SC, et al. Long-term results of St Jude Total Therapy studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:371–82.
Article
CAS
Google Scholar
Pui CH, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC, et al. Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital. Leukemia. 2000;14:2286–94 https://doi.org/10.1038/sj.leu.2401938.
Article
CAS
Google Scholar
Ribeiro RC, Broniscer A, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia. 1997;11:1493–6 https://doi.org/10.1038/sj.leu.2400749.
Article
CAS
Google Scholar
Rivera GK, Pui C-H, Santana VM, Hancock ML, Mahmoud H, Sandlund JT, et al. Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer. 1993;71:3400–5 https://doi.org/10.1002/1097-0142(19930515)71:10+<3400::AID-CNCR2820711744>3.0.CO;2-O.
Rubnitz JE, Behm FG, Pui CH, Evans WE, Relling MV, Raimondi SC, et al. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia. 1997;11:1201–6 https://doi.org/10.1038/sj.leu.2400779.
Article
CAS
Google Scholar
Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998;92:411–5 https://doi.org/10.1182/BLOOD.V92.2.411.
Article
CAS
Google Scholar
S J, CH P. Risk-adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:973–990. https://doi.org/10.1016/J.HOC.2009.07.009.
Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, et al. Results of therapy for acute lymphoblastic leukemia in Black and white children. JAMA. 2003;290:2001–7. https://doi.org/10.1001/JAMA.290.15.2001.
Article
CAS
PubMed
Google Scholar
Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. Blood. 2004;104:2690–6. https://doi.org/10.1182/BLOOD-2004-04-1616.
Article
CAS
PubMed
Google Scholar
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–41. https://doi.org/10.1056/NEJMOA0900386.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol. 2011;29:386–91. https://doi.org/10.1200/JCO.2010.32.0325.
Article
PubMed
Google Scholar
Bhojwani D, Pei D, Sandlund JT, Jeha S, Ribeiro RC, Rubnitz JE, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia. 2012;26:265–70 https://doi.org/10.1038/LEU.2011.227.
Article
CAS
Google Scholar
Kostin AE, Bukhtiiarov IN. An original suture in forming interintestinal anastomoses and in wounds of hollow organs. Vestn Khir Im I I Grek. 1998;157:88.
CAS
PubMed
Google Scholar
Jeha S, Pei D, Choi J, Cheng C, Sandlund JT, Coustan-Smith E, et al. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16. J Clin Oncol. 2019;37:3377–91 https://doi.org/10.1200/JCO.19.01692.
Article
CAS
Google Scholar
Therapy for newly diagnosed patients with acute lymphoblastic leukemia - full text view - ClinicalTrials.gov n.d. https://clinicaltrials.gov/ct2/show/NCT00137111 (Accessed 16 July 2021).
Total Therapy Study XIV for newly diagnosed patients with acute lymphoblastic leukemia - full text view - ClinicalTrials.gov n.d. https://clinicaltrials.gov/ct2/show/NCT00187005 (Accessed 26 July 2021).
Total Therapy XVII for newly diagnosed patients with acute lymphoblastic leukemia and lymphoma - full text view - ClinicalTrials.gov n.d. https://clinicaltrials.gov/ct2/show/NCT03117751 (Accessed 13 Aug 2021).
Winter SS, Dunsmore KP, Devidas M, Wood BL, Esiashvili N, Chen Z, et al. Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children’s Oncology Group AALL0434 methotrexate randomization. J Clin Oncol. 2018;36:2926.
Article
CAS
Google Scholar
Pieters R, Groot-Kruseman H de, Velden V, Fiocco M, Berg H, Bont E de, et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group. J Clin Oncol 2016;34:2591–2601.
Pui C-H, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 2015;33:2938–2948. https://doi.org/10.1200/JCO.2014.59.1636.
Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105:2524–39 https://doi.org/10.3324/haematol.2020.247031.
Article
CAS
Google Scholar
Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330–1336. https://doi.org/10.1056/NEJM199111073251902.
Abrahão R, Ribeiro RC, Brunson A, Keegan THM. The burden of second primary cancers among childhood cancer survivors. Ann Cancer Epidemiol. 2020;4:7–7 https://doi.org/10.21037/ACE-2020-01.
Article
Google Scholar
Youlden DR, Baade PD, Green AC, Valery PC, Moore AS, Aitken JF. Second primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based study. Med J Aust. 2020;212:121–5 https://doi.org/10.5694/MJA2.50425.
Article
Google Scholar
Al-Mahayri ZN, AlAhmad MM, Ali BR. Long-term effects of pediatric acute lymphoblastic leukemia chemotherapy: can recent findings inform old strategies? Front Oncol. 2021;11:4316 https://doi.org/10.3389/FONC.2021.710163/BIBTEX.
Article
Google Scholar
Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci 2017;10:174. https://doi.org/10.3389/FNMOL.2017.00174/BIBTEX.
Howard SC, McCormick J, Pui C-H, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016;21:1471 https://doi.org/10.1634/THEONCOLOGIST.2015-0164.
Article
CAS
Google Scholar
Chabner BA, Young RC. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest. 1973;52:1804 https://doi.org/10.1172/JCI107362.
Article
CAS
Google Scholar
Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer. 2004;100:2222–32 https://doi.org/10.1002/CNCR.20255.
Article
CAS
Google Scholar
Medawar CV, Mosegui GBG, Vianna CM de M, Costa TMA da. PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review. Hematol Transfus Cell Ther 2020;42:54–61. https://doi.org/10.1016/J.HTCT.2019.01.013.
Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O’Brien JE, et al. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial. Lancet Oncol. 2015;16:1677–90 https://doi.org/10.1016/S1470-2045(15)00363-0.
Article
CAS
Google Scholar
Hunger SP, Loh ML, Whitlock JA, Winick NJ, Carroll WL, Devidas M, et al. Children’s Oncology Group’s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:957–63 https://doi.org/10.1002/pbc.24420.
Article
Google Scholar
Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Progr. 2016;2016:580–8 https://doi.org/10.1182/asheducation-2016.1.580.
Article
Google Scholar
Kluk MJ, Lindsley RC, Aster JC, Lindeman NI, Szeto D, Hall D, et al. Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies. J Mol Diagn. 2016;18:507–15 https://doi.org/10.1016/j.jmoldx.2016.02.003.
Article
CAS
Google Scholar
Stock W, Diouf B, Crews KR, Pei D, Cheng C, Laumann K, et al. An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia. Clin Pharmacol Ther. 2017;101:391–5 https://doi.org/10.1002/CPT.506.
Article
CAS
Google Scholar
Wright GEB, Amstutz U, Drögemöller BI, Shih J, Rassekh SR, Hayden MR, et al. Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes. Clin Pharmacol Ther. 2019;105:402–10 https://doi.org/10.1002/CPT.1179.
Article
CAS
Google Scholar
Gutierrez-Camino A, Martin-Guerrero I, Lopez-Lopez E, Echebarria-Barona A, Zabalza I, Ruiz I, et al. Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population. Pharmacogenet Genomics. 2016;26:100–2 https://doi.org/10.1097/FPC.0000000000000191.
Article
CAS
Google Scholar
Diouf B, Crews KR, Evans WE. Vincristine pharmacogenomics: “winner’s curse” or a different phenotype? Pharmacogenet Genomics. 2016;26:51–2 https://doi.org/10.1097/FPC.0000000000000192.
Article
Google Scholar
Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, et al. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 2015;313:815–823. https://doi.org/10.1001/JAMA.2015.0894.
Heikamp EB, Pui CH. Next-generation evaluation and treatment of pediatric acute lymphoblastic leukemia. J Pediatr. 2018;203:14–24.e2 https://doi.org/10.1016/J.JPEDS.2018.07.039.
Article
Google Scholar